Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice (EMTM)

T

Tabula Rasa HealthCare

Status

Completed

Conditions

Medication Therapy Management
Pharmacogenomics

Treatments

Other: Medication therapy management

Study type

Interventional

Funder types

Industry

Identifiers

NCT02748148
MTM-309

Details and patient eligibility

About

The purpose of this study is to identify challenges and successes associated with implementing an enhanced medication therapy management service in primary care practice.

Full description

The specific aim of this study is to implement a Medication Therapy Management (MTM) service in primary care that is enhanced by the incorporation of pharmacogenomics (PGx) and medication risk mitigation (MRM) factor technology and is standardized by a systematic approach to evidence- and personalized-based medicine. The primary objective is to implement the systematic approach to delivering an enhanced MTM service in a primary care setting. Secondary objectives include: determine how successful the communication between prescriber and pharmacist is within implementing the service, determine how PGx testing can be incorporated into primary care prescribers' daily work flow, determine if patients are receptive to PGx testing, determine how satisfied prescribers are with an enhanced MTM clinical service and their confidence to conduct on their own, and determine if enhanced MTM optimizes or changes drug therapy for patients.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Receiving primary health care from Elmwood Family Physicians; and
  • Medicare beneficiary; and
  • Currently prescribed at least 7 medications, or prescriber feels patient would benefit from enhanced medication therapy management, or actual or suspected medication-related problem

Exclusion criteria

  • Not willing to participate in the study and sign informed consent; or
  • Non-English speaking or designated surrogate as translator not available

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Medication therapy management
Experimental group
Description:
Medication therapy management service that is enhanced by the incorporation of pharmacogenomics and medication risk mitigation factor technology
Treatment:
Other: Medication therapy management

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems